首页> 外国专利> MEDICINE FOR IMPROVEMENT OF MENTAL DISORDER SYNDROME

MEDICINE FOR IMPROVEMENT OF MENTAL DISORDER SYNDROME

机译:改善精神障碍综合症的药物

摘要

PURPOSE: To obtain a medicine for improvement of mental disorder syndrome, having an excellent improving effect on fugue, night delirium or aggressive behavior and excellent in safety. ;CONSTITUTION: A medicine for improvement of mental disorder syndrome, containing a compound represented by the formula (R1 is H or OH) or its acid adduct salt, preferably hydrochloride of fasudil as the active component. This compound is administrated in an amount of 0.01 to 20mg/kg.day in the case of parenteral administration and 0.02 to 40mg/kg.day in the case of oral administration. As the dosage form, sterilized liquid is used in the case of parenteral administration and tablet, capsule, powder, granule, liquid, elixir, etc., are used in the case of oral administration.;COPYRIGHT: (C)1994,JPO
机译:目的:获得一种用于改善精神障碍综合症的药物,对赋格症,夜间or妄或攻击行为具有极好的改善效果,并且安全性极好。 ;成分:一种用于改善精神障碍综合症的药物,其中包含以分子式(R 1 为H或OH)表示的化合物或其酸加成盐,优选法舒地尔的盐酸盐作为活性成分。肠胃外给药时该化合物的用量为0.01至20mg / kg。天,口服给药时该化合物的用量为0.02至40mg / kg.day。作为剂型,肠胃外使用无菌液体,口服时使用片剂,胶囊,粉剂,颗粒剂,液体、,剂等。版权所有:(C)1994,日本特许厅

著录项

  • 公开/公告号JPH06293643A

    专利类型

  • 公开/公告日1994-10-21

    原文格式PDF

  • 申请/专利权人 ASAHI CHEM IND CO LTD;

    申请/专利号JP19930078338

  • 发明设计人 KAMEI SATOSHI;SAIKAWA SATOSHI;

    申请日1993-04-05

  • 分类号A61K31/55;

  • 国家 JP

  • 入库时间 2022-08-22 04:53:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号